Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007, to make them more suitable for use in clinical trials that include increasingly complex lesion and patient populations and incorporate novel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) Jg. 137; H. 24; S. 2635
Hauptverfasser: Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-Angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 12.06.2018
Schlagworte:
revascularization
controlled clinical trials
scaffold
stents
myocardial infarction
ISSN:1524-4539, 1524-4539
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007, to make them more suitable for use in clinical trials that include increasingly complex lesion and patient populations and incorporate novel devices such as bioresorbable vascular scaffolds. In addition, recommendations for the incorporation of patient-related outcomes in clinical trials are proposed. Academic Research Consortium-2 is a collaborative effort between academic research organizations in the United States and Europe, device manufacturers, and European, US, and Asian regulatory bodies. Several in-person meetings were held to discuss the changes that have occurred in the device landscape and in clinical trials and regulatory pathways in the last decade. The consensus-based end point definitions in this document are endorsed by the stakeholders of this document and strongly advocated for clinical trial purposes. This Academic Research Consortium-2 document provides further standardization of end point definitions for coronary device trials, incorporating advances in technology and knowledge. Their use will aid interpretation of trial outcomes and comparison among studies, thus facilitating the evaluation of the safety and effectiveness of these devices.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.117.029289